EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY-NC 4.0

The CONFIRM trial protocol: the utility of prostate‐specific membrane antigen positron emission tomography/computed tomography in active surveillance for prostate cancer

Dominic Bagguley, Laurence Harewood, Dean McKenzie, Gideon Ptasznik iD, Sean Ong iD, Thilakavathi Chengodu, Dixon Woon, Kenneth Sim, James Sheldon, Nathan Lawrentschuk iD

BJU International · 2024-04 · 133 (S4) · 27-36

DOI: 10.1111/bju.16214 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift BJU International, online erschienen am 13.11.2023. Verfasst von Dominic Bagguley und 9 weiteren Autor:innen. Beteiligte Einrichtung: EJ Whitten Foundation Prostate Cancer Research Centre at Epworth, Richmond, Victoria, Australia. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Prostatic Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Epworth Medical Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives Primary objectives: To determine the additive value of prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) in the risk stratification of men with newly diagnosed prostate cancer (PCa) who would have otherwise been deemed suitable for active surveillance (AS). Specifically, we aim to determine if PSMA PET/CT can detect a cohort of men on AS that are in fact high risk and likely to experience unfavourable outcomes should they remain on their current treatment pathway. Secondary objectives: to determine the additive value of PSMA PET/CT to repeat multiparametric magnetic resonance imaging (mpMRI) of the prostate and explore whether a confirmatory biopsy may be avoided in men with a negative PSMA PET/CT and a negative repeat mpMRI of the prostate (Prostate Imaging‐Reporting and Data System score of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positron Emission Tomography Computed TomographyProstatic NeoplasmsHumansMaleCohort StudiesFollow-Up StudiesProspective StudiesProstateVictoriaWatchful Waiting

Stichwörter der Autor:innen

18F‐DCFPyLactive surveillanceimagingneedle biopsypositron emission tomographyprostate‐specific membrane antigenprostatic neoplasm

Autor:innen und Institutionen

  • EJ Whitten Foundation Prostate Cancer Research Centre at Epworth, Richmond, Victoria, Australia.
  • Department of Surgery, University of Melbourne, Parkville, Victoria, Australia.
  • Urology Unit, Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Research Development and Governance Unit, Epworth HealthCare, Richmond, Victoria, Australia.
  • Health Sciences and Biostatistics, Swinburne University of Technology, Hawthorn, Victoria, Australia.
  • Division of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

ORCID-Profile: Gideon Ptasznik, Sean Ong, Nathan Lawrentschuk

Förderung

  • Epworth Medical Foundation

Zitieren

APA

Bagguley, D., Harewood, L., McKenzie, D., Ptasznik, G., Ong, S., Chengodu, T., Woon, D., Sim, K., Sheldon, J., & Lawrentschuk, N. (2024). The CONFIRM trial protocol: the utility of prostate‐specific membrane antigen positron emission tomography/computed tomography in active surveillance for prostate cancer. BJU International, 133(S4), 27-36. https://doi.org/10.1111/bju.16214

Vancouver

Bagguley D, Harewood L, McKenzie D, Ptasznik G, Ong S, Chengodu T, et al. The CONFIRM trial protocol: the utility of prostate‐specific membrane antigen positron emission tomography/computed tomography in active surveillance for prostate cancer. BJU International. 2024;133(S4):27-36. doi:10.1111/bju.16214

BibTeX
@article{Bagguley2024,
  author = {Bagguley, Dominic and Harewood, Laurence and McKenzie, Dean and Ptasznik, Gideon and Ong, Sean and Chengodu, Thilakavathi and Woon, Dixon and Sim, Kenneth and Sheldon, James and Lawrentschuk, Nathan},
  title = {The CONFIRM trial protocol: the utility of prostate‐specific membrane antigen positron emission tomography/computed tomography in active surveillance for prostate cancer},
  journal = {BJU International},
  year = {2024},
  volume = {133},
  number = {S4},
  pages = {27--36},
  doi = {10.1111/bju.16214}
}
Kostenlos starten →